Asia
Jefferies Adjusts Emcure Pharmaceuticals' Price Target to INR1,970 From INR1,780, Keeps at Buy
Emcure Pharmaceuticals (NSE:EMCURE, BOM:544210) has an average rating of buy and mean price target of 1,837.33 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
BOM:544210NSE:EMCURE